South Korea Lentiviral Vector Market to 2032
Overview
The South Korea Lentiviral Vector Market is expected to reach a 32.16 USD Million by 2032 and is projected to grow at a CAGR of 24.70% from 2025 to 2032.
Revenue, 2024 (USD Million)
10.18
Forecast, 2032 (USD Million)
32.16
CAGR, 2024 - 2032
24.70%
Report Coverage
South Korea
South Korea Lentiviral Vector Market 2018-2032 USD Million
South Korea Lentiviral Vector Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 10.18 USD Million
- Projected Market Size (2032): 32.16 USD Million
- CAGR (2025-2032): 24.70%
Key Findings of South Korea Lentiviral Vector Market
- The South Korea Lentiviral Vector Market was valued at 10.18 USD Million in 2024.
- The South Korea Lentiviral Vector Market is likely to grow at a CAGR of 24.70% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Gene Therapy in Application Segment accounted for the largest share of the market with a revenue of 7.60 USD Million
- The fastest growing segment Cancer in Disease Indication Segment grew Fastest with a CAGR of 28.72% during the forecast period from 2024 to 2032.
South Korea Lentiviral Vector Market Scope
South Korea Lentiviral Vector Market Segmentation & Scope
Component
- Lentiviral Fusion Tags
- Others
- Lentiviral Promoter
- Lentivirus Packaging Systems
Type
- Services
- Product
Generation
- 1st Generation
- 2nd Generation
- 3rd Generation
- 4th Generation
Application
- Vaccinology
- Gene Therapy
Workflow
- Downstream Processing
- Upstream Processing
End User
- Contract Research Organizations
- Biotechnology Companies
- Contract Development And Manufacturing Organizations
- Pharmaceutical Companies
- Academic/ Research Institutes
Disease Indication
- Others
- Veterinary Diseases
- Infectious Diseases
- Genetic Disorders
- Cancer
Delivery Method
- Ex-Vivo
- In-Vivo
South Korea Lentiviral Vector Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 10.18 USD Million |
| Market Value in 2032 | 32.16 USD Million |
| CAGR (2025-2032) | 24.70% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Component,Type,Generation,Application,Workflow,End User,Disease Indication,Delivery Method |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 10.18 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 10.18 USD Million in 2024.
Segments and Scope
-
South Korea Lentiviral Vector Market to 2032, By Component
- Lentivirus Packaging Systems is the largest segment in South Korea Lentiviral Vector Market to 2032 with a revenue of 5.24 USD Million in the year 2024.
- Lentivirus Packaging Systems is the Fastest growing segment in South Korea Lentiviral Vector Market to 2032 with a Growth rate of 27.32 % in forecast period 2025-2032.
-
South Korea Lentiviral Vector Market to 2032, By Type
- Product is the largest segment in South Korea Lentiviral Vector Market to 2032 with a revenue of 6.16 USD Million in the year 2024.
- Product is the Fastest growing segment in South Korea Lentiviral Vector Market to 2032 with a Growth rate of 26.81 % in forecast period 2025-2032.
-
South Korea Lentiviral Vector Market to 2032, By Generation
- 4th Generation is the largest segment in South Korea Lentiviral Vector Market to 2032 with a revenue of 4.06 USD Million in the year 2024.
- 4th Generation is the Fastest growing segment in South Korea Lentiviral Vector Market to 2032 with a Growth rate of 28.48 % in forecast period 2025-2032.
-
South Korea Lentiviral Vector Market to 2032, By Application
- Gene Therapy is the largest segment in South Korea Lentiviral Vector Market to 2032 with a revenue of 7.60 USD Million in the year 2024.
- Gene Therapy is the Fastest growing segment in South Korea Lentiviral Vector Market to 2032 with a Growth rate of 25.79 % in forecast period 2025-2032.
-
South Korea Lentiviral Vector Market to 2032, By Workflow
- Upstream Processing is the largest segment in South Korea Lentiviral Vector Market to 2032 with a revenue of 7.22 USD Million in the year 2024.
- Upstream Processing is the Fastest growing segment in South Korea Lentiviral Vector Market to 2032 with a Growth rate of 26.02 % in forecast period 2025-2032.
-
South Korea Lentiviral Vector Market to 2032, By End User
- Academic/ Research Institutes is the largest segment in South Korea Lentiviral Vector Market to 2032 with a revenue of 5.17 USD Million in the year 2024.
- Academic/ Research Institutes is the Fastest growing segment in South Korea Lentiviral Vector Market to 2032 with a Growth rate of 27.44 % in forecast period 2025-2032.
-
South Korea Lentiviral Vector Market to 2032, By Disease Indication
- Cancer is the largest segment in South Korea Lentiviral Vector Market to 2032 with a revenue of 4.00 USD Million in the year 2024.
- Cancer is the Fastest growing segment in South Korea Lentiviral Vector Market to 2032 with a Growth rate of 28.72 % in forecast period 2025-2032.
-
South Korea Lentiviral Vector Market to 2032, By Delivery Method
- In-Vivo is the largest segment in South Korea Lentiviral Vector Market to 2032 with a revenue of 6.66 USD Million in the year 2024.
- In-Vivo is the Fastest growing segment in South Korea Lentiviral Vector Market to 2032 with a Growth rate of 26.50 % in forecast period 2025-2032.
South Korea Lentiviral Vector Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Oxford Biomedica | |||
| Lonza | |||
| Thermo Fisher Scientific Inc. | |||
| bluebird bio, Inc. | |||
South Korea Lentiviral Vector Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Lentiviral Vector Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Lentiviral Vector Market is segmented based on Segmentation Component,Type,Generation,Application,Workflow,End User,Disease Indication,Delivery Method.
South Korea Lentiviral Vector Market was valued at USD 10.18(Revenue in USD Million) in 2020.
South Korea Lentiviral Vector Market is projected to grow at a CAGR of 24.70% during the forecast period of 2024 to 2032.
The Gene Therapy segment is expected to dominate the South Korea Lentiviral Vector Market, holding a largest market share of 7.60 USD Million in 2024
South Korea Lentiviral Vector Market Scope
South Korea Lentiviral Vector Market Segmentation & Scope
Component
- Lentiviral Fusion Tags
- Others
- Lentiviral Promoter
- Lentivirus Packaging Systems
Type
- Services
- Product
Generation
- 1st Generation
- 2nd Generation
- 3rd Generation
- 4th Generation
Application
- Vaccinology
- Gene Therapy
Workflow
- Downstream Processing
- Upstream Processing
End User
- Contract Research Organizations
- Biotechnology Companies
- Contract Development And Manufacturing Organizations
- Pharmaceutical Companies
- Academic/ Research Institutes
Disease Indication
- Others
- Veterinary Diseases
- Infectious Diseases
- Genetic Disorders
- Cancer
Delivery Method
- Ex-Vivo
- In-Vivo
Frequently Asked Questions
The South Korea Lentiviral Vector Market is segmented based on Segmentation Component,Type,Generation,Application,Workflow,End User,Disease Indication,Delivery Method.
South Korea Lentiviral Vector Market was valued at USD 10.18(Revenue in USD Million) in 2020.
South Korea Lentiviral Vector Market is projected to grow at a CAGR of 24.70% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Lentiviral Vector Market for final year is USD 32.16 (USD Million).
South Korea Lentiviral Vector Market Company Profiling
Frequently Asked Questions
The South Korea Lentiviral Vector Market is segmented based on Segmentation Component,Type,Generation,Application,Workflow,End User,Disease Indication,Delivery Method.
South Korea Lentiviral Vector Market was valued at USD 10.18(Revenue in USD Million) in 2020.
South Korea Lentiviral Vector Market is projected to grow at a CAGR of 24.70% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Lentiviral Vector Market for final year is USD 32.16 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.